Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0WD6K
|
|||
| Former ID |
DIB007179
|
|||
| Drug Name |
VPM-4-001
|
|||
| Synonyms |
Allogenic LNCaP cell vaccine (prostate tumor), Vakzine Projekt Management; Cell vaccine (prostate cancer), Vakzine Projekt Management; Allogenic LNCaP cells (IL-2, IFN-gamma), Vakzine Projekt Management
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Prostate cancer [ICD-11: 2C82.0; ICD-10: C61; ICD-9: 185] | Preclinical | [1] | |
| Company |
Memorial Sloan-Kettering Cancer Center
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800023655) | |||
| REF 2 | BioPartnering North America--Programs from Pharma in Europe and the Middle East. IDrugs. 2010 Mar;13(3):162-5. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.